PUBLISHED DATE : Nov 2021 | Pages : 284
Fill out your details & get your free sample
Active Pharmaceutical Ingredients Market Size, Share, & Trends Analysis Report By
Application: Oncology, Cardiovascular Disease, Anti-infectives, Central Nervous System, Respiratory diseases, Diabetes, Pain management, and Others
Molecule Type: Small and Large
Type of manufacturers: Captive and Merchant
Type of drugs: Prescription and Over the counter
Synthesis Type: Synthetic and Biotech
Geography: North America, Europe, APAC, Latin America, and the Middle East & Africa
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021–2026.
284 Pages
133 Tables
89 Charts
5 Regions
18 Countries
25 Companies
6 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (REVENUE) | USD 266.80 BILLION (2026) |
| CAGR | 6.22% (2021-2026) |
| BASE YEAR | 2020 |
| FORECAST YEAR | 2021-2026 |
| MARKET SEGMENTS | Application (Oncology, Cardiovascular Disease, Anti-infectives, Central Nervous System, Respiratory diseases, Diabetes, Pain management, and Others), Molecule Type (Small and Large), Type of manufacturers (Captive and Merchant), Type of drugs (Prescription and Over the counter), and Synthesis Type (Synthetic and Biotech) |
| GEOGRAPHIC ANALYSIS | North America, Europe, APAC, Latin America, and Middle East & Africa |
| COUNTRIES COVERED | US, Canada, United Kingdom, Germany, France, Italy, Spain, Russia, China, India, Indonesia, Japan, Singapore, Brazil, Mexico, Saudi Arabia, South Africa, and UAE |
The global active pharmaceutical ingredients (API) market size was valued at USD 185.72 billion in 2020 and is expected to reach USD 266.80 billion by 2026, growing at a compound annual growth rate (CAGR) of 6.22%.
Digitalization, big data, and artificial intelligence are accelerating the transformation of the pharmaceutical industry. The growing trend toward new high-tech therapeutics, with the emergence of novel and innovative delivery systems and the evolution of personalized medicines, will further emphasize the growing demand for advanced Aher. Innovative and Biotech APIs are fueling the demand for APIs across the globe. The global active pharmaceutical ingredient (API) market is set to have significant growth in the forecasted period. The growth of the market can be amplified by the growing geriatric and aging population globally. Manufacturers are significantly investing in Research and development and must continue spending on research and development initiatives. As the industry is getting fragmented and profit margins are thin, there is a need for constant innovation.
The North American region is highly fragmented, and many global and regional players are present in the active pharmaceutical ingredient market. Pharmaceutical manufacturers have increased the investments in R&D for the development of better-quality APIs since it has a direct effect on the safety and efficacy of the drug. The North American API industry is anticipated to show increasing growth in the forecasted period.
The European market grew with the increase in technological advancements to enhance the capabilities and boost the manufacturing skills of the players. The active pharmaceutical ingredients market in Europe is expected to reach almost USD 50 billion in the coming years.
The global API market is highly concentrated and competitive. Pfizer, Cipla, Novartis AG, Mylan NV, and Sun Pharmaceuticals are prominent vendors in the industry. Over the past decade, several companies have engaged in mergers and acquisitions to establish their presence in the industry. Mergers and acquisitions offer several benefits, such as better access to procuring raw materials, distribution, and R&D, and are largely driven by consolidation. Manufacturers must always keep pace with the latest industry regulations for manufacturing APIs to avoid penalties and criminal sanctions. The demand for APIs is expected to accelerate due to the increase in the geriatric population and the increase in awareness for better healthcare.
Frequently Asked Questions
How big is the active pharmaceutical ingredient market?
The active pharmaceutical ingredients (API) market is expected to reach USD 266.80 billion by 2026.
What are the different applications in the global active pharmaceutical ingredient market?
Oncology, Cardiovascular Disease, Anti-infectives, Central Nervous System, Respiratory diseases, Diabetes, Pain management, and Others are the different applications in the global active pharmaceutical ingredient market.
Who are the key players in the active pharmaceutical ingredient (API) market?
Pfizer Inc., Cipla Inc., Novartis AG, Mylan N.V., and Sun Pharmaceuticals Industries Ltd. are the key players in the active pharmaceutical ingredient (API) market.
What are the latest trends in the active pharmaceutical ingredient market?
Current trends like an increase in demand for biopharmaceuticals and naturally derived APIs will increase the demand and growth.
What are the key driving factors in the global API market?
The invention of new generation API and increase in demand for generic drugs.
The active pharmaceutical ingredients market is expected to reach USD 266.80 billion by 2026, growing at a CAGR of 6.22%.
The following factors are likely to contribute to the growth of the active pharmaceutical ingredients market during the forecast period:
Base Year: 2020
Forecast Year: 2021- 2026
The study considers a detailed scenario of the present active pharmaceutical ingredients market and its market dynamics for the period 2021−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Key Vendors
Other Prominent Vendors
Market Segmentation by Application
Market Segmentation by Molecule Type
Market Segmentation by Type of manufacturers
Market Segmentation by Type of drugs
Market Segmentation by Synthesis Type
Market Segmentation by Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.01.01 Inclusions
4.01.02 Exclusions
4.01.03 Market Estimation Caveats
4.2 Base Year
4.3 Scope Of The Study
4.03.01 Market Segmentation By Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.2 Impact Of Covid-19
8 Growth Opportunity By Segment
8.1 By Application
8.2 By Molecule
8.3 By Manufacturers
8.4 By Synthesis
8.5 By Drug Type
8.6 By Geography
9 Market Opportunities &Trends
9.1 Growing Demand For Generic Drugs
9.2 Increasing Digitalization In Healthcare
9.3 Mergers & Acquisitions In Pharmaceutical Industry
10 Market Growth Enablers
10.1 Invention Of New Generation APIs
10.2 Growth In API Outsourcing Operations
11 Market Growth Restraints
11.1 Stringent Government Regulations
11.2 Analytical Challenges In Testing Processes
12 Market Landscape
12.1 Market Overview
12.2 Market Size & Forecast
12.3 Five Forces Analysis
12.03.01 Threat Of New Entrants
12.03.02 Bargaining Power Of Suppliers
12.03.03 Bargaining Power Of Buyers
12.03.04 Threat Of Substitutes
12.03.05 Competitive Rivalry
13 Application
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Oncology
13.03.01 Market Overview
13.03.02 Market Size & Forecast
13.03.03 Market By Geography
13.4 Diabetes
13.04.01 Market Overview
13.04.02 Market Size & Forecast
13.04.03 Market By Geography
13.5 Cardiovascular
13.05.01 Market Overview
13.05.02 Market Size & Forecast
13.05.03 Market By Geography
13.6 Respiratory Diseases
13.06.01 Market Overview
13.06.02 Market Size & Forecast
13.06.03 Market By Geography
13.7 Pain Management
13.07.01 Market Overview
13.07.02 Market Size & Forecast
13.07.03 Market By Geography
13.8 Anti-Infectives
13.08.01 Market Overview
13.08.02 Market Size & Forecast
13.08.03 Market By Geography
13.9 Central Nervous System
13.09.01 Market Overview
13.09.02 Market Size & Forecast
13.09.03 Market By Geography
14 Molecule Size
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Small Molecule
14.03.01 Market Overview
14.03.02 Market Size & Forecast
14.03.03 Market By Geography
14.4 Large Molecule
14.04.01 Market Overview
14.04.02 Market Size & Forecast
14.04.03 Market By Geography
15 Type Of Manufacturers
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Captive Manufacturing
15.03.01 Market Overview
15.03.02 Market Size & Forecast
15.03.03 Market By Geography
15.4 Merchant Manufacturing
15.04.01 Market Overview
15.04.02 Market Size & Forecast
15.04.03 Market By Geography
16 Types Of Drugs
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Over-The-Counter Drugs
16.03.01 Market Overview
16.03.02 Market Size & Forecast
16.03.03 Market By Geography
16.4 Prescription Drugs
16.04.01 Market Overview
16.04.02 Market Size & Forecast
16.04.03 Market By Geography
17 Synthesis Type
17.1 Market Snapshot & Growth Engine
17.2 Market Overview
17.3 Synthetic API
17.03.01 Market Overview
17.03.02 Market Size & Forecast
17.03.03 Market By Geography
17.4 Biotech API
17.04.01 Market Overview
17.04.02 Market Size & Forecast
17.04.03 Market By Geography
18 Geography
18.1 Market Snapshot & Growth Engine
18.2 Geographic Overview
19 North America
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Application
19.03.01 Market Size & Forecast
19.4 Molecule
19.04.01 Market Size & Forecast
19.5 Manufacturers
19.05.01 Market Size & Forecast
19.6 Synthesis Type
19.06.01 Market Size & Forecast
19.7 Type Of Drugs
19.07.01 Market Size & Forecast
19.8 Key Countries
19.08.01 Us: Market Size & Forecast
19.08.02 Canada: Market Size & Forecast
20 Europe
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Application
20.03.01 Market Size & Forecast
20.4 Molecule
20.04.01 Market Size & Forecast
20.5 Manufacturers
20.05.01 Market Size & Forecast
20.6 Synthesis Type
20.06.01 Market Size & Forecast
20.7 Type Of Drugs
20.07.01 Market Size & Forecast
20.8 Key Countries
20.08.01 UK: Market Size & Forecast
20.08.02 Germany: Market Size & Forecast
20.08.03 France: Market Size & Forecast
20.08.04 Italy: Market Size & Forecast
20.08.05 Spain: Market Size & Forecast
20.08.06 Russia: Market Size & Forecast
21 APAC
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Application
21.03.01 Market Size & Forecast
21.4 Molecule
21.04.01 Market Size & Forecast
21.5 Manufacturers
21.05.01 Market Size & Forecast
21.6 Synthesis Type
21.06.01 Market Size & Forecast
21.7 Type Of Drugs
21.07.01 Market Size & Forecast
21.8 Key Countries
21.08.01 China: Market Size & Forecast
21.08.02 India: Market Size & Forecast
21.08.03 Indonesia: Market Size & Forecast
21.08.04 Japan: Market Size & Forecast
21.08.05 Singapore: Market Size & Forecast
22 Latin America
22.1 Market Overview
22.2 Market Size & Forecast
22.3 Application
22.03.01 Market Size & Forecast
22.4 Molecule
22.04.01 Market Size & Forecast
22.5 Manufacturers
22.05.01 Market Size & Forecast
22.6 Synthesis Type
22.06.01 Market Size & Forecast
22.7 Type Of Drugs
22.07.01 Market Size & Forecast
22.8 Key Countries
22.08.01 Brazil: Market Size & Forecast
22.08.02 Mexico: Market Size & Forecast
23 Middle East & Africa
23.1 Market Overview
23.2 Market Size & Forecast
23.3 Application
23.03.01 Market Size & Forecast
23.4 Molecule
23.04.01 Market Size & Forecast
23.5 Manufacturers
23.05.01 Market Size & Forecast
23.6 Synthesis Type
23.06.01 Market Size & Forecast
23.7 Type Of Drugs
23.07.01 Market Size & Forecast
23.8 Key Countries
23.08.01 Saudi Arabia: Market Size & Forecast
23.08.02 South Africa: Market Size & Forecast
23.08.03 UAE: Market Size & Forecast
24 Competitive Landscape
24.1 Competition Overview
25 Key Company Profiles
25.1 PFIZER INC.
25.01.01 Business Overview
25.01.02 Pfizer Inc. in Global Active Pharmaceutical Ingredients Market
25.01.03 Product Offerings
25.01.04 Key Strategies
25.01.05 Key Strengths
25.01.06 Key Opportunities
25.2 CIPLA INC.
25.02.01 Business Overview
25.02.02 Cipla Inc. in Global Active Pharmaceutical Ingredients Market
25.02.03 Product Offerings
25.02.04 Key Strategies
25.02.05 Key Strengths
25.02.06 Key Opportunities
25.3 NOVARTIS AG
25.03.01 Business Overview
25.03.02 Novartis AG in Active pharmaceutical ingredients Market
25.03.03 Product Offerings
25.03.04 Key Strategies
25.03.05 Key Strengths
25.03.06 Key Opportunities
25.4 MYLAN N.V.
25.04.01 Business Overview
25.04.02 Mylan N.V. in Global Active Pharmaceutical Ingredients Market
25.04.03 Product Offerings
25.04.04 Key Strategies
25.04.05 Key Strengths
25.04.06 Key Opportunities
25.5 SUN PHARMACEUTICAL INDUSTRIES LTD.
25.05.01 Business Overview
25.05.02 Sun Pharmaceutical Industries Ltd. in Global Active Pharmaceutical Ingredients Market
25.05.03 Product Offerings
25.05.04 Key Strategies
25.05.05 Key Strengths
25.05.06 Key Opportunities
26 Other Prominent Vendors
26.1 ALBEMARLE CORPORATION
26.01.01 Business Overview
26.01.02 Key Highlights
26.2 ABBVIE INC.
26.02.01 Business Overview
26.02.02 Key Highlights
26.3 DR. REDDY’S LABORATORIES LTD.
26.03.01 Business Overview
26.03.02 Key Highlights
26.4 ELI LILLY AND COMPANY
26.04.01 Business Overview
26.04.02 Key Highlights
26.5 TEVA PHARMACEUTICAL INDUSTRIES LTD.
26.05.01 Business Overview
26.05.02 Key Highlights
26.6 BRISTOL-MYERS SQUIBB
26.06.01 Business Overview
26.06.02 Key Highlights
26.7 AUROBINDO PHARMA
26.07.01 Business Overview
26.07.02 Key Highlights
26.8 SANOFI
26.08.01 Business Overview
26.08.02 Key Highlights
26.9 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
26.09.01 Business Overview
26.09.02 Key Highlights
26.10 BASF SE
26.10.01 Business Overview
26.10.02 Key Highlights
26.11 LUPIN
26.11.01 Business Overview
26.11.02 Key Highlights
26.12 SHENZHEN HEPALINK PHARMACEUTICAL GROUP
26.12.01 Business Overview
26.12.02 Key Highlights
26.13 ABBOTT
26.13.01 Business Overview
26.13.02 Key Highlights
26.14 BIOCON
26.14.01 Business Overview
26.14.02 Key Highlights
26.15 AMGEN INC.
26.15.01 Business Overview
26.15.02 Key Highlights
26.16 GLAXOSMITHKLINE PLC.
26.16.01 Business Overview
26.16.02 Key Highlights
26.17 F. HOFFMANN-LA ROCHE LTD.
26.17.01 Business Overview
26.17.02 Key Highlights
26.18 MERCK KGAA
26.18.01 Business Overview
26.18.02 Key Highlights
26.19 VIATRIS INC.
26.19.01 Business Overview
26.19.02 Key Highlights
26.20 GLENMARK PHARMACEUTICALS
26.20.01 Business Overview
26.20.02 Key Highlights
27 Report Summary
27.1 Key Takeaways
27.2 Strategic Recommendations
28 Quantitative Summary
28.1 Application
28.01.01 Oncology
28.01.02 Cardiovascular Disease
28.01.03 Anti-infectives
28.01.04 CNS
28.01.05 Pain Management
28.01.06 Diabetes
28.01.07 Respiratory Disease
28.2 MOLECULE TYPE
28.02.01 Small Molecule
28.02.02 Large Molecule API
28.3 SYNTHESIS TYPE
28.03.01 Synthetic API
28.03.02 Biotech API
28.4 MANUFACTURERS
28.04.01 Captive Manufacturing
28.04.02 Merchant Manufacturing
28.5 DRUG TYPE
28.05.01 Over-the-counter drugs
28.05.02 Prescription Drugs API
28.6 GEOGRAPHY
28.06.01 North America
28.06.02 Europe
28.06.03 APAC
28.06.04 Latin America
28.06.05 Middle East and Africa
29 Appendix
29.1 Abbreviations
LIST OF EXHIBITS
Exhibit 1 Segmentation of Global Active Pharmaceutical Ingredients Market
Exhibit 2 Market Size Calculation Approach 2020
Exhibit 3 Market Size of Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 4 Biotech API Manufacturing Process
Exhibit 5 Synthetic API Manufacturing Process
Exhibit 6 Growth Drivers in Global Active Pharmaceutical Ingredients Market
Exhibit 7 Global Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Exhibit 8 Global Active Pharmaceutical Ingredients Market by Molecule ($ billion)
Exhibit 9 Global Active Pharmaceutical Ingredients Market by Manufacturing ($ billion)
Exhibit 10 Global Active Pharmaceutical Ingredients Market by Synthesis ($ billion)
Exhibit 11 Global Active Pharmaceutical Ingredients Market by Drug Type ($ billion)
Exhibit 12 Global Active Pharmaceutical Ingredients Market by Geography ($ billion)
Exhibit 13 Impact of Growing Demand for Generic Drugs
Exhibit 14 Definition of Generic Medicine
Exhibit 15 Types of Generics
Exhibit 16 Impact of Increasing Digitalization in Healthcare
Exhibit 17 Impact of Mergers and Acquisitions in Pharmaceutical Industry
Exhibit 18 Strategies for Mergers & Acquisitions
Exhibit 19 Impact of Invention of New Generation APIs
Exhibit 20 Challenges with Peptide APIs
Exhibit 21 Impact of Growth in API Outsourcing Operations
Exhibit 22 Advantages of Outsourcing
Exhibit 23 Impact of Stringent Government Regulations
Exhibit 24 Impact of Analytical Challenges in Testing Processes
Exhibit 25 Current Trends in Global APIs Market
Exhibit 26 Global Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 27 Five Forces Analysis 2020
Exhibit 28 Incremental Growth by Application 2020 & 2026
Exhibit 29 Global Oncology Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 30 Global Diabetes Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 31 Global Cardiovascular Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 32 Global Respiratory Diseases Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 33 Global Pain Management Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 34 Global Anti-infective Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 35 Global CNS Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 36 Incremental Growth by Molecule 2020 & 2026
Exhibit 37 Global Active Pharmaceutical Ingredients Market by Molecule Size (% share)
Exhibit 38 Global Small Molecule Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 39 Global Large Molecule Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 40 Incremental Growth by Manufacturing 2020 & 2026
Exhibit 41 Advantages of Merchant Manufacturing
Exhibit 42 Advantages of Captive Manufacturing
Exhibit 43 Global Captive Manufacturing Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 44 Challenges in Outsourcing
Exhibit 45 Advantages of Contract Manufacturing
Exhibit 46 Global Merchant Manufacturing APIs Market 2020–2026 ($ billion)
Exhibit 47 Incremental Growth by Drugs 2020 & 2026
Exhibit 48 Key Differences
Exhibit 49 Global OTC Drugs Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 50 Global Prescription Drugs Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 51 Incremental Growth by Synthesis 2020 & 2026
Exhibit 52 Global Synthetic Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 53 Global Biotech Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 54 Incremental Growth by Geography 2020 & 2026
Exhibit 55 Global Active Pharmaceutical Ingredients Market by Region (CAGR %)
Exhibit 56 North America Active Pharmaceutical Ingredients Market 2020–2026
Exhibit 57 North America Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 58 Incremental Growth in North America 2020 & 2026
Exhibit 59 Active Pharmaceutical Ingredients Market in US 2020–2026 ($ billion)
Exhibit 60 Active Pharmaceutical Ingredients Market in Canada 2020–2026 ($ billion)
Exhibit 61 Factors Fueling Success of CMOs in Europe
Exhibit 62 Europe Global Active Pharmaceutical Ingredients Market
Exhibit 63 Europe Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 64 Incremental Growth in Europe 2020 & 2026
Exhibit 65 Active Pharmaceutical Ingredients Market in UK 2020–2026 ($ billion)
Exhibit 66 Active Pharmaceutical Ingredients Market in Germany 2020–2026 ($ billion)
Exhibit 67 Active Pharmaceutical Ingredients Market in France 2020–2026 ($ billion)
Exhibit 68 Active Pharmaceutical Ingredients Market in Italy 2020–2026 ($ billion)
Exhibit 69 Active Pharmaceutical Ingredients Market in Spain 2020–2026 ($ billion)
Exhibit 70 Active Pharmaceutical Ingredients Market in Russia 2020–2026 ($ billion)
Exhibit 71 APAC Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 72 Incremental Growth in APAC 2020 & 2026
Exhibit 73 Active Pharmaceutical Ingredients Market in China 2020–2026 ($ billion)
Exhibit 74 Active Pharmaceutical Ingredients Market in India 2020–2026 ($ billion)
Exhibit 75 Challenges Faced by Indian API Industry
Exhibit 76 Active Pharmaceutical Ingredients Market in Indonesia 2020–2026 ($ billion)
Exhibit 77 Active Pharmaceutical Ingredients Market in Japan 2020–2026 ($ billion)
Exhibit 78 Active Pharmaceutical Ingredients Market in Singapore 2020–2026 ($ billion)
Exhibit 79 Latin America Global Active Pharmaceutical Ingredients Market
Exhibit 80 Latin America Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 81 Incremental Growth in Latin America 2020 & 2026
Exhibit 82 Active Pharmaceutical Ingredients Market in Brazil 2020–2026 ($ billion)
Exhibit 83 Active Pharmaceutical Ingredients Market in Mexico 2020–2026 ($ billion)
Exhibit 84 Middle East & Africa Active Pharmaceutical Ingredients Market
Exhibit 85 Middle East & Africa Active Pharmaceutical Ingredients Market 2020–2026 ($ billion)
Exhibit 86 Incremental Growth in Middle East & Africa 2020 & 2026
Exhibit 87 Active Pharmaceutical Ingredients Market in Saudi Arabia 2020–2026 ($ billion)
Exhibit 88 Active Pharmaceutical Ingredients Market in South Africa 2020–2026 ($ billion)
Exhibit 89 Active Pharmaceutical Ingredients Market in UAE 2020–2026 ($ billion)
LIST OF TABLES
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2020
Table 3 Global Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 4 Global Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 5 Global Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 6 Global Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 7 Global Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 8 Global Pharmaceutical Ingredients Market by Region 2020–2026 ($ billion)
Table 9 Global Oncology APIs Market by Geography 2020–2026 ($ billion)
Table 10 Global Diabetes APIs Market by Geography 2020–2026 ($ billion)
Table 11 Global Cardiovascular APIs Market by Geography 2020–2026 ($ billion)
Table 12 Global Respiratory Diseases APIs Market by Geography 2020–2026 ($ billion)
Table 13 Global Pain Management APIs Market by Geography 2020–2026 ($ billion)
Table 14 Global Anti-infective APIs Market by Geography 2020–2026 ($ billion)
Table 15 Global Central Nervous System APIs Market by Geography 2020–2026 ($ billion)
Table 16 Global Small Molecule APIs Market by Geography 2020–2026 ($ billion)
Table 17 Global Large Molecule APIs Market by Geography 2020–2026 ($ billion)
Table 18 Global Captive Manufacturing APIs Market by Geography 2020–2026 ($ billion)
Table 19 Global Merchant Manufacturing APIs Market by Geography 2020–2026 ($ billion)
Table 20 Global Over-the-counter APIs Market by Geography 2020–2026 ($ billion)
Table 21 Global Prescription Drug APIs Market by Geography 2020–2026 ($ billion)
Table 22 Global Synthetic APIs Market by Geography 2020–2026 ($ billion)
Table 23 Global Biotech APIs Market by Geography 2020–2026 ($ billion)
Table 24 North America Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 25 North America Active Pharmaceutical Ingredients by Molecule 2020–2026 ($ billion)
Table 26 North America Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 27 North America Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 28 North America Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 29 Europe Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 30 Europe Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 31 Europe Active Pharmaceutical Ingredients Market by Manufacturing 2020–2026 ($ billion)
Table 32 Europe Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 33 Europe Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 34 APAC Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 35 APAC Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 36 APAC Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 37 APAC Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 38 APAC Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 39 Latin America Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 40 Latin America Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 41 Latin America Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 42 Latin America Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 43 Latin America Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 44 MEA Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 45 MEA Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 46 MEA Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 47 MEA Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 48 MEA Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 49 Pfizer Inc.: Major Product Offerings
Table 50 Cipla Inc.: Major Product Offerings
Table 51 Novartis AG: Major Product Offerings
Table 52 Mylan N.V.: Major Product Offerings
Table 53 Sun Pharmaceutical Industries Ltd.: Major Product Offerings
Table 54 Global Oncology Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 55 Global Oncology Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 56 Global Cardiovascular Disease Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 57 Global Cardiovascular Disease Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 58 Global Anti-infectives Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 59 Global Anti-infectives Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 60 Global CNS Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 61 Global CNS Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 62 Global Pain Management Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 63 Global Pain Management Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 64 Global Diabetes Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 65 Global Diabetes Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 66 Global Respiratory Disease Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 67 Global Respiratory Disease Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 68 Global Small Molecule Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 69 Global Small Molecule Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 70 Global Large Molecule Active Pharmaceutical Ingredients Market by Geography 2020–2026 ($ billion)
Table 71 Global Large Molecule Active Pharmaceutical Ingredients Market by Geography 2020–2026 (% share)
Table 72 Global Synthetic Active Pharmaceutical Ingredients Market by Geography 2020−2026 ($ billion)
Table 73 Global Synthetic Active Pharmaceutical Ingredients Market by Geography 2020−2026 (% share)
Table 74 Global Biotech Active Pharmaceutical Ingredients Market by Geography 2020−2026 ($ billion)
Table 75 Global Biotech Active Pharmaceutical Ingredients Market by Geography 2020−2026 (% share)
Table 76 Global Captive Manufacturing Active Pharmaceutical Ingredients Market by Geography 2020−2026 ($ billion)
Table 77 Global Captive Manufacturing Active Pharmaceutical Ingredients Market by Geography 2020−2026 (% share)
Table 78 Global Merchant Manufacturing Active Pharmaceutical Ingredients Market by Geography 2020−2026 ($ billion)
Table 79 Global Merchant Manufacturing Active Pharmaceutical Ingredients Market by Geography 2020−2026 (% share)
Table 80 Global OTC Drug Active Pharmaceutical Ingredients Market by Geography 2020−2026 ($ billion)
Table 81 Global OTC Drug Active Pharmaceutical Ingredients Market by Geography 2020−2026 (% share)
Table 82 Global Prescription Drugs Active Pharmaceutical Ingredients Market by Geography 2020−2026 ($ billion)
Table 83 Global Prescription Drugs Active Pharmaceutical Ingredients Market by Geography 2020−2026 (% share)
Table 84 North America Active Pharmaceutical Ingredients Market by Application 2020−2026 ($ billion)
Table 85 North America Active Pharmaceutical Ingredients Market by Application 2020−2026 (% share)
Table 86 North America Active Pharmaceutical Ingredients Market by Molecule 2020−2026 ($ billion)
Table 87 North America Active Pharmaceutical Ingredients Market by Molecule 2020−2026 (% share)
Table 88 North America Active Pharmaceutical Ingredients Market by Manufacturing 2020−2026 ($ billion)
Table 89 North America Active Pharmaceutical Ingredients Market by Manufacturing 2020−2026 (% share)
Table 90 North America Active Pharmaceutical Ingredients Market by Synthesis 2020−2026 ($ billion)
Table 91 North America Active Pharmaceutical Ingredients Market by Synthesis 2020−2026 (% share)
Table 92 North America Active Pharmaceutical Ingredients Market by Drugs 2020−2026 ($ billion)
Table 93 North America Active Pharmaceutical Ingredients Market by Drugs 2020−2026 (% share)
Table 94 Europe Active Pharmaceutical Ingredients Market by Application 2020−2026 ($ billion)
Table 95 Europe Active Pharmaceutical Ingredients Market by Application 2020−2026 (% share)
Table 96 Europe Active Pharmaceutical Ingredients Market by Molecule 2020−2026 ($ billion)
Table 97 Europe Active Pharmaceutical Ingredients Market by Molecule 2020−2026 (% share)
Table 98 Europe Active Pharmaceutical Ingredients Market by Manufacturing 2020−2026 ($ billion)
Table 99 Europe Active Pharmaceutical Ingredients Market by Manufacturing 2020−2026 (% share)
Table 100 Europe Active Pharmaceutical Ingredients Market by Synthesis 2020−2026 ($ billion)
Table 101 Europe Active Pharmaceutical Ingredients Market by Synthesis 2020−2026 (% share)
Table 102 Europe Active Pharmaceutical Ingredients Market by Drugs 2020−2026 ($ billion)
Table 103 Europe Active Pharmaceutical Ingredients by Drugs 2020−2026 (% share)
Table 104 APAC Active Pharmaceutical Ingredients Market by Application 2020−2026 ($ billion)
Table 105 APAC Active Pharmaceutical Ingredients Market by Application 2020−2026 (% share)
Table 106 APAC Active Pharmaceutical Ingredients Market by Molecule 2020−2026 ($ billion)
Table 107 APAC Active Pharmaceutical Ingredients Market by Molecule 2020−2026 (% share)
Table 108 APAC Active Pharmaceutical Ingredients Market by Manufacturers 2020−2026 ($ billion)
Table 109 APAC Active Pharmaceutical Ingredients Market by Manufacturers 2020−2026 (% share)
Table 110 APAC Active Pharmaceutical Ingredients Market by Synthesis 2020−2026 ($ billion)
Table 111 APAC Active Pharmaceutical Ingredients Market by Synthesis 2020−2026 (% share)
Table 112 APAC Active Pharmaceutical Ingredients Market by Drugs 2020−2026 ($ billion)
Table 113 APAC Active Pharmaceutical Ingredients Market by Drugs 2020−2026 (% share)
Table 114 Latin America Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 115 Latin America Active Pharmaceutical Ingredients Market by Application 2020–2026 (% share)
Table 116 Latin America Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 117 Latin America Active Pharmaceutical Ingredients Market by Molecule 2020–2026 (% share)
Table 118 Latin America Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 119 Latin America Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 (% share)
Table 120 Latin America Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 121 Latin America Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 (% share)
Table 122 Latin America Active Pharmaceutical Ingredients Market by Drugs 2020−2026 ($ billion)
Table 123 Latin America Active Pharmaceutical Ingredients Market by Drugs 2020–2026 (% share)
Table 124 MEA Active Pharmaceutical Ingredients Market by Application 2020–2026 ($ billion)
Table 125 MEA Active Pharmaceutical Ingredients Market by Application 2020–2026 (% share)
Table 126 MEA Active Pharmaceutical Ingredients Market by Molecule 2020–2026 ($ billion)
Table 127 MEA Active Pharmaceutical Ingredients Market by Molecule 2020–2026 (% share)
Table 128 MEA Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 ($ billion)
Table 129 MEA Active Pharmaceutical Ingredients Market by Manufacturers 2020–2026 (% share)
Table 130 MEA Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 ($ billion)
Table 131 MEA Active Pharmaceutical Ingredients Market by Synthesis 2020–2026 (% share)
Table 132 MEA Active Pharmaceutical Ingredients Market by Drugs 2020–2026 ($ billion)
Table 133 MEA Active Pharmaceutical Ingredients Market by Drugs 2020–2026 (% share)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
